Manufactured into plasma-derived therapies Rare Disease Patients Single Donor Transfusion Manufactured into Hyperimmune Ig (Pooled from many donors, processed & standardized) SOURCE PLASMA COVID-19 CONVALESCENT PLASMA (CCP) PLASMA TREATMENTS: IMPORTANT DISTINCTIONS BLOOD CLOTTING FACTORS: Hemophilia, Von Willebrand disease ALPHA-1 PROTEINASE INHIBITOR: Alpha-1 antitrypsin deficiency ALBUMIN: Certain liver conditions, Burns, Shock, Trauma IMMUNOGLOBULIN (IG): Primary Immunodeficiency diseases, GBS/CIDP, Kawasaki disease, Secondary antibody deficiencies (Cancer), MIS-C, COVID-19 C1 ESTERASE INHIBITOR (C1-INH): Hereditary Angioedema High Risk Individuals COVID-19 Patients AUGUST 2020 #PlasmaDonorsSaveLives FOR MORE INFORMATION AND WAYS TO DONATE, VISIT: WWW.DONATINGPLASMA.ORG